AU Stock MarketDetailed Quotes

RADO Radiopharm Theranostics Ltd

Watchlist
  • 0.004
  • 0.0000.00%
20min DelayTrading Oct 30 12:00 AET
8.69MMarket Cap0.00P/E (Static)

Radiopharm Theranostics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Total revenue
2.35%299.23K
3,210.60%292.36K
8.83K
Operating revenue
2.35%299.23K
3,210.60%292.36K
--8.83K
Cost of revenue
Gross profit
2.35%299.23K
3,210.60%292.36K
8.83K
Operating expense
6.09%36.92M
74.66%34.8M
19.93M
Selling and administrative expenses
16.87%15.22M
20.03%13.02M
--10.85M
-General and administrative expense
16.87%15.22M
20.03%13.02M
--10.85M
Research and development costs
27.24%17.56M
234.58%13.8M
--4.12M
Depreciation amortization depletion
-5.16%3.13M
10.57%3.3M
--2.98M
-Depreciation and amortization
-5.16%3.13M
10.57%3.3M
--2.98M
Other operating expenses
-78.30%1.02M
137.56%4.68M
--1.97M
Operating profit
-6.12%-36.62M
-73.27%-34.51M
-19.92M
Net non-operating interest income (expenses)
-1,105.03%-592.4K
100.63%58.94K
-9.35M
Non-operating interest income
-65.19%50.48K
--145.04K
----
Non-operating interest expense
646.75%642.89K
-99.08%86.09K
--9.35M
Other net income (expenses)
-8,476.92%-10.64M
87.94%-124.05K
-1.03M
Special income (charges)
52.29%-1.48M
---3.1M
----
-Less:Impairment of capital assets
-52.29%1.48M
--3.1M
----
Other non-operating income (expenses)
-407.82%-9.16M
389.35%2.98M
---1.03M
Income before tax
-38.41%-47.85M
-14.12%-34.57M
-30.29M
Income tax
153.56%96.36K
-14.40%38.01K
44.4K
Earnings from equity interest net of tax
Net income
-38.54%-47.95M
-14.08%-34.61M
-30.34M
Net income continuous operations
-38.54%-47.95M
-14.08%-34.61M
---30.34M
Noncontrolling interests
Net income attributable to the company
-38.54%-47.95M
-14.08%-34.61M
-30.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-38.54%-47.95M
-14.08%-34.61M
-30.34M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022
Total revenue 2.35%299.23K3,210.60%292.36K8.83K
Operating revenue 2.35%299.23K3,210.60%292.36K--8.83K
Cost of revenue
Gross profit 2.35%299.23K3,210.60%292.36K8.83K
Operating expense 6.09%36.92M74.66%34.8M19.93M
Selling and administrative expenses 16.87%15.22M20.03%13.02M--10.85M
-General and administrative expense 16.87%15.22M20.03%13.02M--10.85M
Research and development costs 27.24%17.56M234.58%13.8M--4.12M
Depreciation amortization depletion -5.16%3.13M10.57%3.3M--2.98M
-Depreciation and amortization -5.16%3.13M10.57%3.3M--2.98M
Other operating expenses -78.30%1.02M137.56%4.68M--1.97M
Operating profit -6.12%-36.62M-73.27%-34.51M-19.92M
Net non-operating interest income (expenses) -1,105.03%-592.4K100.63%58.94K-9.35M
Non-operating interest income -65.19%50.48K--145.04K----
Non-operating interest expense 646.75%642.89K-99.08%86.09K--9.35M
Other net income (expenses) -8,476.92%-10.64M87.94%-124.05K-1.03M
Special income (charges) 52.29%-1.48M---3.1M----
-Less:Impairment of capital assets -52.29%1.48M--3.1M----
Other non-operating income (expenses) -407.82%-9.16M389.35%2.98M---1.03M
Income before tax -38.41%-47.85M-14.12%-34.57M-30.29M
Income tax 153.56%96.36K-14.40%38.01K44.4K
Earnings from equity interest net of tax
Net income -38.54%-47.95M-14.08%-34.61M-30.34M
Net income continuous operations -38.54%-47.95M-14.08%-34.61M---30.34M
Noncontrolling interests
Net income attributable to the company -38.54%-47.95M-14.08%-34.61M-30.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -38.54%-47.95M-14.08%-34.61M-30.34M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data